Evaluation of Effect of pioglitazone on decreasing of proteinuria in type II diabetic patients with nephropathy.
Phase 3
Recruiting
- Conditions
- Diabetic Nephropathy.E10.2Insulin-de
- Registration Number
- IRCT2017080210222N10
- Lead Sponsor
- Vice chancellor for research of Shahrekord University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Inclution Criteria: 24-hour urine protein over 250 mg / day or the ratio of albumin to creatinine over 30 mg/g
Exclusion Criteria
Hypothyroidism and heart failure; HbA1C is less than 8; Blood pressure less than 160/100; Creatinine less than 2; GFR greater than 50
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 24-hour urine protein. Timepoint: 2 month after intervention. Method of measurement: sampling.
- Secondary Outcome Measures
Name Time Method Albumin level. Timepoint: 2month after intervention. Method of measurement: sampling.;Creatinin level. Timepoint: 2month after intervention. Method of measurement: sampling.